Literature DB >> 18668436

SLC28 genes and concentrative nucleoside transporter (CNT) proteins.

M Pastor-Anglada1, P Cano-Soldado, E Errasti-Murugarren, F J Casado.   

Abstract

The human concentrative nucleoside transporter (hCNT) protein family has three members, hCNT1, 2, and 3, encoded by SLC28A1, A2, and A3 genes, respectively. hCNT1 and hCNT2 translocate pyrimidine- and purine-nucleosides, respectively, by a sodium-dependent mechanism, whereas hCNT3 shows broad substrate selectivity and the unique ability of translocating nucleosides both in a sodium- and a proton-coupled manner. hCNT proteins are also responsible for the uptake of most nucleoside-derived antiviral and anticancer drugs. Thus, hCNTs are key pharmacological targets. This review focuses on several crucial aspects of hCNT biology and pharmacology: protein structure-function, structural determinants for transportability, pharmacogenetics of hCNT-encoding genes, role of hCNT proteins in nucleoside-based therapeutics, and finally hCNT physiology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18668436     DOI: 10.1080/00498250802069096

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  18 in total

Review 1.  The role of transporters in the toxicity of nucleoside and nucleotide analogs.

Authors:  Christopher A Koczor; Rebecca A Torres; William Lewis
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-04-18       Impact factor: 4.481

2.  Dilazep analogues for the study of equilibrative nucleoside transporters 1 and 2 (ENT1 and ENT2).

Authors:  Hilaire Playa; Timothy A Lewis; Amal Ting; Byung-Chul Suh; Benito Muñoz; Robert Matuza; Brent J Passer; Stuart L Schreiber; John K Buolamwini
Journal:  Bioorg Med Chem Lett       Date:  2014-10-28       Impact factor: 2.823

Review 3.  Drug transporters in the central nervous system.

Authors:  Bruno Stieger; Bo Gao
Journal:  Clin Pharmacokinet       Date:  2015-03       Impact factor: 6.447

4.  The Concise Guide to PHARMACOLOGY 2013/14: transporters.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

5.  Nucleoside transporters and human organic cation transporter 1 determine the cellular handling of DNA-methyltransferase inhibitors.

Authors:  C Arimany-Nardi; E Errasti-Murugarren; G Minuesa; J Martinez-Picado; V Gorboulev; H Koepsell; M Pastor-Anglada
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

6.  Effects of Na+ and H+ on steady-state and presteady-state currents of the human concentrative nucleoside transporter 3 (hCNT3).

Authors:  Edurne Gorraitz; Marçal Pastor-Anglada; Maria Pilar Lostao
Journal:  Pflugers Arch       Date:  2010-05-22       Impact factor: 3.657

7.  A metal-containing nucleoside that possesses both therapeutic and diagnostic activity against cancer.

Authors:  Jung-Suk Choi; Ayan Maity; Thomas Gray; Anthony J Berdis
Journal:  J Biol Chem       Date:  2015-02-24       Impact factor: 5.157

8.  Molecular determinants of acidic pH-dependent transport of human equilibrative nucleoside transporter 3.

Authors:  Md Fazlur Rahman; Candice Askwith; Rajgopal Govindarajan
Journal:  J Biol Chem       Date:  2017-07-20       Impact factor: 5.157

9.  Genetic and clinical determinants of mizoribine pharmacokinetics in renal transplant recipients.

Authors:  Rui Dai; Jingjie Li; Jingjing Wu; Qian Fu; Jiajia Yan; Guoping Zhong; Changxi Wang; Xiao Chen; Pan Chen
Journal:  Eur J Clin Pharmacol       Date:  2020-08-15       Impact factor: 2.953

10.  Analysis and update of the human solute carrier (SLC) gene superfamily.

Authors:  Lei He; Konstandinos Vasiliou; Daniel W Nebert
Journal:  Hum Genomics       Date:  2009-01       Impact factor: 4.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.